GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rhinomed Ltd (ASX:RNO) » Definitions » Pre-Tax Income

Rhinomed (ASX:RNO) Pre-Tax Income : A$-10.91 Mil (TTM As of Jun. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Rhinomed Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Rhinomed's pretax income for the six months ended in Jun. 2023 was A$-6.25 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2023 was A$-10.91 Mil. Rhinomed's pretax margin was -152.95%.

During the past 13 years, Rhinomed's highest Pretax Margin was -57.99%. The lowest was -1859.24%. And the median was -212.78%.


Rhinomed Pre-Tax Income Historical Data

The historical data trend for Rhinomed's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhinomed Pre-Tax Income Chart

Rhinomed Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.93 -7.27 -8.64 -5.28 -10.91

Rhinomed Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.15 -3.25 -2.03 -4.65 -6.25

Competitive Comparison of Rhinomed's Pre-Tax Income

For the Medical Devices subindustry, Rhinomed's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rhinomed's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Rhinomed's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Rhinomed's Pre-Tax Income falls into.



Rhinomed Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Rhinomed's Pretax Income for the fiscal year that ended in Jun. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-9.094+-1.503+-0.293+0.003+-0.020000000000001
=-10.91

Rhinomed's Pretax Income for the quarter that ended in Jun. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-3.95+-2.064+-0.223+0.002+-0.018999999999999
=-6.25

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-10.91 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rhinomed  (ASX:RNO) Pre-Tax Income Explanation

Rhinomed's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-6.254/4.089
=-152.95%

During the past 13 years, Rhinomed's highest Pretax Margin was -57.99%. The lowest was -1859.24%. And the median was -212.78%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rhinomed Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Rhinomed's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Rhinomed (ASX:RNO) Business Description

Traded in Other Exchanges
Address
132 Gwynne Street, Level 1, Cremorne, VIC, AUS, 3121
Rhinomed Ltd is a medical technology company, with a patented nasal technology platform. It is engaged in the research, development and commercialization of consumer and medical devices including nasal, respiratory and nasal drug delivery technologies. It operates in one segment which is the identification, acquisition, and commercialization of late-stage consumer therapeutic and medical delivery technologies. The products of the company involve Rhinoswab, Mute, Turbine and Rhinoswab Junior. It operates geographically within North, Central, and South America, Asia-Pacific, Europe, Middle East, and Africa. The company earns majority of its revenue from Asia-Pacific.

Rhinomed (ASX:RNO) Headlines

No Headlines